Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142227 |
| CAS No | NA |
| Mol.F. | C14H18N6O4 |
| Mol.Wt. | 334.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142228 |
| CAS No | NA |
| Mol.F. | C9H19N3O4 |
| Mol.Wt. | 233.27 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142229 |
| CAS No | NA |
| Mol.F. | C17H19N3OS |
| Mol.Wt. | 313.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142230 |
| CAS No | NA |
| Mol.F. | C17H19N3O2S |
| Mol.Wt. | 329.42 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142231 |
| CAS No | NA |
| Mol.F. | C29H26N4OS2 |
| Mol.Wt. | 510.67 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142232 |
| CAS No | NA |
| Mol.F. | C6H5N7O2 |
| Mol.Wt. | 207.15 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142233 |
| CAS No | NA |
| Mol.F. | C6H8N4O3 |
| Mol.Wt. | 184.16 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142234 |
| CAS No | NA |
| Mol.F. | C7H8N4O4 |
| Mol.Wt. | 212.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142235 |
| CAS No | NA |
| Mol.F. | C12H13N5O5 |
| Mol.Wt. | 307.27 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142236 |
| CAS No | NA |
| Mol.F. | C8H7N7O3 |
| Mol.Wt. | 249.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142237 |
| CAS No | NA |
| Mol.F. | C8H7N7O3 |
| Mol.Wt. | 249.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142238 |
| CAS No | NA |
| Mol.F. | C5H5N5O3 |
| Mol.Wt. | 183.13 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142239 |
| CAS No | NA |
| Mol.F. | C4H5N5O2 |
| Mol.Wt. | 155.12 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142240 |
| CAS No | NA |
| Mol.F. | C16H15N5O2 |
| Mol.Wt. | 309.32 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142241 |
| CAS No | NA |
| Mol.F. | C17H17N5O3 |
| Mol.Wt. | 339.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142242 |
| CAS No | NA |
| Mol.F. | C12H11N3O2 |
| Mol.Wt. | 229.24 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |